Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Infinity Pharmaceuticals Inc (NASDAQ:INFI)

1.44
Delayed Data
As of Dec 09
 +0.08 / +5.88%
Today’s Change
0.84
Today|||52-Week Range
8.16
-81.66%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 4
2015
Quarter 1
2016
Quarter 2
2016
Quarter 3
2016
Revenue and IncomeNet Revenues9.1M9.3M9.5M0.00
 
 
 
 
Depreciation And Amortization735.0K693.0K693.0K1.2M
 
 
 
 
 
 
Operating ExpensesGross Income-------1.2M
 
 
General Expenses47.5M49.3M51.3M21.2M
 
 
 
 
 
Research And Development38.9M39.2M41.0M14.3M
 
 
 
 
 
Total Operating Expenses48.2M50.0M52.0M22.3M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-39.2M-40.8M-42.5M-22.3M
 
 
 
 
 
Extraordinary Credit0.000.00112.2M2.9M
 
 
 
Extraordinary Charge0.000.00-16.6M--
 
 
Interest Expense On Debt310.0K309.0K307.0K305.0K
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-39.3M-40.7M53.0M-19.5M
 
 
 
 
 
Income Taxes-145.0K0.000.000.00
 
 
Net Income-39.2M-40.7M51.9M-19.5M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS49.2M49.3M49.4M49.6M
 
 
 
 
 
Shares To Calculate EPS Diluted49.2M49.3M49.4M49.6M
 
 
 
 
 
 
Earnings Per ShareEPS-$0.80-$0.82$1.05-$0.39
 
 
 
 
 
EPS Diluted-$0.80-$0.82$1.05-$0.39